PreciseTumor: payments to doctors
Payments that named PreciseTumor as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $415K
- Providers
- 1,499
- Transactions
- 2,695
- Average per transaction
- $154
The per-transaction average — $154 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,499 providers the average total is $277, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Myriad Genetic Laboratories, Inc. | $414,686 | 99.8% |
| Myriad Women's Health, Inc. | $777 | 0.2% |